Abstract
Plant-derived natural products have been an important source of several clinically useful anti-cancer agents. Plants continue to play a major role in drug discovery as evidenced by the number of promising new agents in clinical development based on selective activity against cancer-related molecular targets. Due to improvements in tumor targeting technology, some agents which failed in earlier clinical studies are also stimulating renewed interest. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are possibly produced by endophytic fungi and microbes residing in the plant tissues. We consider that this area of natural product research should be expanded significantly.
Keywords: Plant-derived natural products, anticancer, antitumor, targeted agents, endophytes, Natural Products, Anticancer Drug, cancer-related molecular targets, natural product drugs, endophytic fungi, taxanes, camptothecins, bioactive compounds, semi-synthetic, synthetic analogs, tumor cells, competitive inhibition, Vinca Alkaloids, vinorelbine, cancers, leukemias, lymphomas, breast and lung cancers, Kaposi's sarcoma, Epi-Podophyllotoxins, podophyllotoxin, etoposide, teniposide, colorectal cancers, Plant-derived Clinical Agents, homoharringtonine (HHT), acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), complete hematologic remission (CHR), elliptinium (Celiptium), Combretastatins, combretistatin A4 phosphate (CA4), flavopriidol (Alvocidib), rohitukine, olomucine, roscovitine, purvalanol A purvalanol B, Ingenol-3-Angelate, Triptolide, maytansine, Bruceantin, Indirubins, 6-bromoindirubin, 6-bromoindirubin oxime, Silvestrol, epi-Silvestrol, withacnistin A, Emericellamide A
Current Organic Chemistry
Title: Plant Natural Products in Anticancer Drug Discovery
Volume: 14 Issue: 16
Author(s): Paul G. Grothaus, Gordon M. Cragg and David J. Newman
Affiliation:
Keywords: Plant-derived natural products, anticancer, antitumor, targeted agents, endophytes, Natural Products, Anticancer Drug, cancer-related molecular targets, natural product drugs, endophytic fungi, taxanes, camptothecins, bioactive compounds, semi-synthetic, synthetic analogs, tumor cells, competitive inhibition, Vinca Alkaloids, vinorelbine, cancers, leukemias, lymphomas, breast and lung cancers, Kaposi's sarcoma, Epi-Podophyllotoxins, podophyllotoxin, etoposide, teniposide, colorectal cancers, Plant-derived Clinical Agents, homoharringtonine (HHT), acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), complete hematologic remission (CHR), elliptinium (Celiptium), Combretastatins, combretistatin A4 phosphate (CA4), flavopriidol (Alvocidib), rohitukine, olomucine, roscovitine, purvalanol A purvalanol B, Ingenol-3-Angelate, Triptolide, maytansine, Bruceantin, Indirubins, 6-bromoindirubin, 6-bromoindirubin oxime, Silvestrol, epi-Silvestrol, withacnistin A, Emericellamide A
Abstract: Plant-derived natural products have been an important source of several clinically useful anti-cancer agents. Plants continue to play a major role in drug discovery as evidenced by the number of promising new agents in clinical development based on selective activity against cancer-related molecular targets. Due to improvements in tumor targeting technology, some agents which failed in earlier clinical studies are also stimulating renewed interest. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are possibly produced by endophytic fungi and microbes residing in the plant tissues. We consider that this area of natural product research should be expanded significantly.
Export Options
About this article
Cite this article as:
G. Grothaus Paul, M. Cragg Gordon and J. Newman David, Plant Natural Products in Anticancer Drug Discovery, Current Organic Chemistry 2010; 14 (16) . https://dx.doi.org/10.2174/138527210792927708
DOI https://dx.doi.org/10.2174/138527210792927708 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemistry in the Bioactivity of Chlorophylls: An Overview
Current Medicinal Chemistry COX-2 Selective Inhibitors, Carbonic Anhydrase Inhibition and Anticancer Properties of Sulfonamides Belonging to This Class of Pharmacological Agents
Mini-Reviews in Medicinal Chemistry Molecular Profiles of Sentinel and Non-Sentinel Lymph Nodes in Breast Cancer Progression and Prognosis
Current Cancer Therapy Reviews Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective
Anti-Cancer Agents in Medicinal Chemistry Nicotine Addiction and Coronary Artery Disease: Impact of Cessation Interventions
Current Pharmaceutical Design PET Imaging of Multidrug Resistance in Tumors Using 18F-Fluoropaclitaxel
Current Topics in Medicinal Chemistry Dietary Agents for Prostate Cancer Chemoprevention: An Overview
Current Cancer Therapy Reviews Enhanced Floating and Intragastric Release of 5-Flourouracil through Sesame Oil Entrapped Gellan Composite Hydrogel Beads
Current Drug Therapy Imaging Adoptive Cell Transfer Based Cancer Immunotherapy
Current Pharmaceutical Biotechnology FOXM1 and its Oncogenic Signaling in Gastric Cancer
Recent Patents on Anti-Cancer Drug Discovery Mechanisms to Inhibit Matrix Metalloproteinase Activity: Where are we in the Development of Clinically Relevant Inhibitors?
Recent Patents on Anti-Cancer Drug Discovery Silibinin – A Promising New Treatment for Cancer
Anti-Cancer Agents in Medicinal Chemistry Cancer Prevention and Therapy in a Preclinical Mouse Model: Impact of FHIT Viruses
Current Gene Therapy Statins and Type 2 Diabetes Mellitus: An Update After 1 Year
Current Pharmaceutical Design Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
Current Cancer Drug Targets Specific Hemosiderin Deposition in Spleen Induced by a Low Dose of Cisplatin: Altered Iron Metabolism and Its Implication as an Acute Hemosiderin Formation Model
Current Drug Metabolism Genetic and Molecular Approaches to the Immunopathogenesis of Multiple Sclerosis: An Update
Current Molecular Medicine Oxygen Sensing, Cardiac Ischemia, HIF-1α and Some Emerging Concepts
Current Cardiology Reviews LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention
Recent Patents on Anti-Cancer Drug Discovery Current and Next Generation Topical Anti-Skin Cancer Therapeutics
Drug Delivery Letters